Concepedia

Author

Lisa Squassante

GlaxoSmithKline (Italy)

Also Known As

L Squassante, L. Squassante, Lisa Squassante, Lisa Squassante,, Squassante, L, Squassante, Lisa

69

Publications

2.5K

Citations

25

H-Index

82

Concepts

All Affiliations

GlaxoSmithKline (Italy)Roche (Switzerland)GlaxoSmithKline (United Kingdom)Roche (United Kingdom)Ospedaliera di Piacenza
LS

About

Lisa Squassante is an author at GlaxoSmithKline (Italy) specializing in medicine, pharmacology, and social sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

16

705

2

Social Sciences

5

5

312

3

Health Sciences

4

4

246

4

Public Health

3

3

109

5

Cell Biology

1

1

33

Lisa Squassante

×

36

Publications

2.4K

Citations

25

H-Index

YearCitations

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.

Sandro Rossi, M. Stasi, Elisabetta Buscarini,

American Journal of Roentgenology

1996

759

A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder

Federico Bolognani, Marta del Valle Rubido, Lisa Squassante,

Science Translational Medicine

2019

120

Absolute Quantification of Cerebral Blood Flow with Magnetic Resonance, Reproducibility of the Method, and Comparison with H<sub>2</sub><sup>15</sup>O Positron Emission Tomography

Timothy J. Carroll, Vincenzo Teneggi, Mathieu Jobin,

Journal of Cerebral Blood Flow & Metabolism

2002

103

Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study

James Stone, Kjell Erlandsson, Erik Årstad,

Psychopharmacology

2008

101

Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep, and EEG Power Spectra in a Model of Situational Insomnia

P. Bettica, Lisa Squassante, John A. Groeger,

Neuropsychopharmacology

2012

93

Assessment of Cognitive Scales to Examine Memory, Executive Function and Language in Individuals with Down Syndrome: Implications of a 6-month Observational Study

Xavier Liogier D’ardhuy, Jamie O. Edgin, Charles Bouis,

Frontiers in Behavioral Neuroscience

2015

90

The Orexin Antagonist SB-649868 Promotes and Maintains Sleep in Men with Primary Insomnia

P. Bettica, Lisa Squassante, Stefano Zamuner,

SLEEP

2012

86

Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal

Vincenzo Teneggi, Stephen T. Tiffany, Lisa Squassante,

Psychopharmacology

2002

80

A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder

Daniel Umbricht, Marta del Valle Rubido, Eric Hollander,

Neuropsychopharmacology

2016

76

Results From 2 Randomized, Double-Blind, Placebo-Controlled Studies of the Novel NK1 Receptor Antagonist Casopitant in Patients With Major Depressive Disorder

Emiliangelo Ratti, Kevin M. Bellew, P. Bettica,

Journal of Clinical Psychopharmacology

2011

64

Page 1